STUDresearch · Peptide
Human Growth Hormone (somatropin)
Also known as
HGH · rhGH · somatropin · recombinant human growth hormone · 191aa GH · 191 AA HGH · somatotrophin / somatotropin (legacy spellings) · somatrem / met-HGH / 192aa (historical / gray-market contrast) · Genotropin-class discussion · Norditropin-class discussion · Omnitrope-class discussion · Humatrope-class discussion · Nutropin-class discussion · Serostim-class discussion (HIV wasting context) · pharma GH / “pharma grade” talk
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Peptide
Lots of talk
Systemic
SubQ / IM
Growth hormone axis
Systemic — binds GH receptors widely; hepatic IGF-1 and whole-body metabolic/body-composition effects.
What people say
HGH here means injectable recombinant 191-amino-acid somatropin, a prescription hormone that directly activates GH receptors and raises downstream IGF-1; it is not a secretagogue, steroid, fragment, spray, or pill.
Doses people talk about
Rows preserve what people reported without endorsing a ladder. Labeled replacement is individualized; gray-market identity and delivered IU remain uncertain.
How it may feel
No single acute feel dominates. Reports include no obvious effect, early water and hand symptoms, stiffness, lethargy, and better or worse sleep; body-composition impressions are usually judged over several months.
Community wellness talkAbout 1–2 IU/day
Off-label anti-aging/wellness discussion, not an approved indication.
Community entry physique talkAbout 2 IU/day
Frequently reported as a first long-block amount for fat-loss or recovery goals.
Community recomp talkAbout 2–4 IU/day
Common multi-month forum band with unverified products and substantial diet/training confounding.
Higher physique talkAbout 4–6 IU/day
More aggressive use where edema, carpal symptoms and glucose concerns appear more often in discussion.
Elite-use loreAbout 6–10+ IU/day
High-dose anecdotes with greater long-horizon acromegaloid and metabolic concern; not a validated athletic regimen.
Adult GHD labelingAbout 0.15–0.30 mg/day starting range
GENOTROPIN non-weight-based start, with later individualization rather than a fixed endpoint.
Half-life & effect duration
- Half-life in the body
- Genotropin · under-the-skin injectionAbout 3 hours
- Genotropin · IVAbout 24 minutes
- Felt duration people report
- During useWater retention, tingling, lethargy, better or worse sleep, or no effect
- Physique changesJudged over months and longer
Cycles people discuss
GHD replacement is continuous and supervised. Forum blocks range from roughly 8–16 weeks to 3–6 months or longer, with 5-on/2-off and other variants reflecting cost or side-management culture rather than a validated reset rule.
Timing
Morning-fasted, bedtime and split AM/PM use are competing community routines. Meal-spacing and fat-loss rationales remain lore; other users emphasize adherence, and post-workout timing is a minority practice.
Stacks
Testosterone / AAS + HGH: The classic mass or recomp stack; GH often credited for fat loss and “quality” while AAS drive most strength/size — high confound and additive side burden.
Access talk
Three shelves: brand pens (Genotropin / Norditropin / Omnitrope-class), diverted/pharma-looking kits, and research-chem “191aa” vials. IU labels on gray kits are the authenticity fight.
Labs people mention
IGF-1 (age-adjusted, same lab) is the exposure surrogate people titrate. Morning draw; some hold the AM pin so fasting glucose isn’t an acute GH artifact.
Watch for
Glucose / insulin resistance / diabetes risk: GH is diabetogenic in susceptible people — fasting glucose, OGTT, and HbA1c monitoring are standard caution language.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
GENOTROPIN labeling measured a mean 3.0-hour terminal half-life after subcutaneous dosing in adults with GHD.
The studied SC dose was 0.03 mg/kg, mean Tmax was 5.9 hours, and the terminal-half-life 95% confidence interval was 2.2–3.7 hours; IV in healthy adults was about 0.4 hour.
Specific to GENOTROPIN, the studied dose, route and population. Other products and long-acting GH preparations differ, and unverified kits are not certified by the label.
- DailyMed — GENOTROPIN (somatropin) prescribing information (opens in a new tab)Dosage and Administration; Clinical Pharmacology 12.3 Pharmacokinetics; adult GHD adverse reactions. The label identifies 191-amino-acid somatropin, subcutaneous use, a non-weight adult start around 0.2 mg/day (0.15–0.30 mg/day range), 0.1–0.2 mg/day changes every 1–2 months, and after 0.03 mg/kg SC in adult GHD mean Tmax 5.9 h and terminal half-life 3.0 h (95% CI 2.2–3.7); IV half-life in healthy adults was 0.4 h.Product-specific US prescribing information. The SC PK result is for GENOTROPIN in adult GHD after a weight-based dose and does not make every formulation, population, or gray-market vial exposure-equivalent.
Felt duration people report
No reproducible felt-duration window emerges from the inspected threads.
Users described null effects, water retention, tingling, lethargy, better or worse sleep, and slowly judged physique changes across months-long and multi-year use at varied reported amounts.
Anonymous unblinded reports, unverified product identity and IU, varying diagnoses and frequent AAS or other co-use. Cross-user frequency cannot establish prevalence or connect subjective persistence to somatropin clearance.
- Reddit r/steroids — Compounds: Human Growth Hormone (HGH) (opens in a new tab)Thread and visible first-person replies describing 2–4 IU/day and higher regimens, AM/PM splits, months-long use, null or subtle response, water retention, hand tingling/carpal symptoms, lethargy, sleep differences, a blood-pressure rise during a confounded AAS stack, and multi-year body-change anecdotes.Anonymous retrospective reports with unverified products, varied doses and durations, frequent AAS or other co-use, selection bias, and no controlled attribution. Route and delivered amount are not independently verified.
- Reddit r/steroids — Compound Experience Thread: HGH (opens in a new tab)Thread and visible first-person replies describing roughly 2–8 IU/day, split schedules, several-month to multi-year runs, water and hand symptoms, better sleep in some, lethargy or little noticeable effect in others, and slowly judged body-composition goals.Anonymous self-reports; products, dosing accuracy, diagnoses, diet, training and concurrent drug use are unverified. Cross-user comments cannot establish prevalence or a causal felt-duration window.
What people say
- Recovery feel: Multi-week logs claim easier session-to-session recovery and joint comfort — heavily confounded by sleep, diet, AAS, and expectancy. forum
- Skin / collagen / anti-aging look: Thicker skin, nail/hair talk, and “younger face” are common wellness anecdotes; stronger clinical collagen language exists than gym-only selfies prove. anecdote
- Sleep: Some report deeper sleep with evening dosing; others report no change or worse sleep if edema/glucose noise dominates. forum
- Cognitive / energy talk: Wellness blogs claim clearer energy; not a robust athletic-performance endpoint in short GH trials. forum
- Connective tissue lore: Forums credit GH for tendon/ligament resilience over long cycles; controlled proof in healthy lifters is thin. anecdote
- Stack synergy narrative: Classic physique claim is that GH “shows” more when layered with AAS (mass/hardness) and/or insulin (nutrient partitioning / fullness) — attribution is confounded. forum
- No classic steroid PCT need (alone): Community generally treats HGH-only as not requiring SERM PCT the way AAS do; endogenous GH suppression talk exists but return is often described as days-scale, not weeks-long HPTA crash. forum
- Vs secretagogues: Direct somatropin is framed as more predictable IU→IGF-1 than CJC/Ipa, GHRPs, or MK-677, at higher cost and injection burden (and different side profile). forum
- 2025–26 IGF-1 titration stories: Physique logs still treat a rising age-adjusted IGF-1 plus water/carpal as “the vial is real,” then argue how much fat vs fluid the look is. forum
- Subcutaneous fat loss (headline aesthetic claim): Community and clinic talk emphasize lipolysis and softer midsection/definition over pure strength; body-comp reviews often show fat mass down alongside lean mass up. trial
- Lean mass / “scale muscle”: Short athletic meta-style summaries frequently cite ~several pounds lean-mass increase over weeks — partly extracellular water, not pure myofibrillar tissue. trial
- Strength / capacity caveat: Same athletic reviews often fail to show clear strength or VO2/capacity gains despite lean-mass change — a core bro vs trial tension. trial
- GHD replacement outcomes: Adult deficiency treatment can improve body composition and quality-of-life endpoints when titrated to IGF-1 and sides under endocrine care. trial
- HIV wasting / cachexia context: Approved high-dose somatropin regimens (e.g., Serostim-class discussion) target lean body mass and endurance in that indication — not a physique “beginner” template. trial
Doses people talk about
- Wellness / “replacement-ish” band (community): ~1–2 IU SC daily is a common anti-aging/wellness-thread floor for adults without diagnosed GHD — modest recomp/sleep talk, fewer extreme sides than mass doses. forum
- Entry physique band: ~2 IU/day is a frequent first long-block dose for fat loss / recovery goals in forum charts. forum
- Common recomp / aesthetic band: ~2–4 IU/day is the modal bodybuilding discussion range for multi-month blocks (fat loss + lean look). forum
- Upper common physique band: ~4–6 IU/day for more aggressive mass/recomp talk; edema, CTS, and glucose complaints rise. forum
- Elite / pro bodybuilding talk: ~6–10+ IU/day (sometimes higher in old lore and mega-dose anecdotes) — more permanent side-effect risk narratives (including acromegaly-range concerns in long high-dose use). forum
- Female community talk: Often described lower than male mass charts (commonly overlapping ~1–2 IU wellness / low-recomp bands in secondary guides) with same edema/CTS/glucose watch-outs; primary controlled female physique data is thin. forum
- Single daily vs split: Classic is once daily SC. Split AM+PM (e.g., half/half) is discussed to smooth peaks, glucose load, or when total IU is high; evidence that split beats once-daily for aesthetics is forum opinion, not settled trials. forum
- 5 days on / 2 days off: Very common cost-saving and “desensitization” chart; total weekly IU lower than true ED at same daily number — anecdotal, not a proven receptor-reset law. forum
- EOD (every other day): Same weekly total, larger per-injection IU; debated vs daily for IGF-1 stability and sides — mixed forum preference. forum
- Fasted / low-carb window lore: Some time doses away from large carb meals for lipolysis narrative; others prioritize adherence over perfect fasted timing. forum
- Post-workout dose talk: Minority stack timing with training; less canonical than bedtime or AM fasted. forum
- Titration practice (community): Start low, hold 2–4+ weeks, raise only if sides allow and goals unmet — opposite of “blast IU day one.” forum
- Authenticity uncertainty: If edema/IGF-1 never move at chart doses, underdosed or fake product is a first-line community suspicion. forum
- 2025–26 extra camps: Bedtime full IU (classic); AM fasted for fat-loss lore; split AM+PM at higher totals; 5-on/2-off; EOD. IGF-1 often similar AM vs PM in older clinical timing work — forums still pick a camp. forumtrial
- Wellness 1–2 IU vs physique 2–4 IU is still the named split; 6–10+ IU stays elite-lore with more acromegaloid/glucose talk. forum
- Kit math ≠ secretagogue blend math: IU on a somatropin kit is not 100/100 mcg. Gray “36 IU kits” vs brand pens are different identity problems. forum
- Framing: Discussed clinical and community ranges only — not medical advice, not prescriptions, not safety-validated athletic protocols. Gray-market IU labels may not match true content. forum
- Morning fasted dosing (lifter debate): Growing bro argument that intact endogenous night pulse + bedtime exogenous GH may worsen overnight insulin resistance; some prefer AM fasted for fat-loss framing. Morning vs evening clinical work generally finds similar growth/IGF-1 with evening better mimicking physiology — not a pure “AM wins for everyone” proof. forum
- Adult GHD start (clinical): Often ~0.15–0.3 mg/day (~0.5–1 IU) SC, titrated by IGF-1, clinical response, and sides — age-stratified starts appear in clinic guides (older adults lower). trial
- Adult GHD titration talk: Clinic blogs describe stepping by ~0.1–0.2 mg/day (~0.3–0.6 IU) every 1–2 months toward IGF-1 mid-normal and tolerability. trial
- Bedtime dosing (classic medical mimic): Aligns with nocturnal GH pulse lore; still the default clinical and many wellness protocols. trial
- Conversion (standard clinical convention): ~3 IU ≈ 1 mg somatropin (1 IU ≈ 0.33 mg). Always verify the specific product label; kit math errors are common. trial
- HIV wasting context (not a gym template): Label-style discussions include weight-based high daily doses (e.g., Serostim-class 0.1 mg/kg/day talk) — order-of-magnitude higher than wellness IU charts. trial
How it may feel
- No acute “buzz”: Unlike stimulants or some peptides, first injections usually feel nothing systemically — water and stiffness are the early signals, not euphoria. forum
- Days 1–7: Mild puffiness, ring/finger tightness, ankle water, or joint stiffness can start; sleep shifts for some on bedtime dosing. forum
- Weeks 3–4: Soft midsection / fuller muscle look talk increases; scale may rise from fluid even as waist claims improve — photo and tape often preferred over weight alone. forum
- Weeks 4–8: If product is real and diet supports, fat-loss and recovery narratives dominate recomp logs; non-responders reassess authenticity before auto-raising IU. forum
- Months 2–3: Physique “this is why people pay for it” window in many 2–4 IU/day recomp stories; glucose/insulin resistance talk becomes more serious at higher IU. forum
- Very long (years): Case anecdotes of hat/shoe size change, jaw/hand growth, and organ/soft-tissue remodeling with multi-year high exposure — irreversible risk frame. anecdote
- 2026 early signal is still water, not a buzz: Rings, ankles, morning stiffness, carpal tingle — people cut IU rather than “push through” bad CTS. forum
- Sleep split: Evening dose can feel like deeper sleep *or* worse sleep if edema/glucose noise dominates. AM fasted camp reports less night restlessness and more “lipolysis ritual.” forum
- Weeks 1–2: Edema, carpal-tunnel-like tingling, and morning stiffness are the common “it’s working / dose too high” checkpoint; many cut IU rather than push through severe CTS. trial
- Months 3–6+: Longer blocks for wellness or slow recomp; recheck fasting glucose, HbA1c, IGF-1, and blood pressure; chronic high-dose acromegaloid change is the long-horizon fear. trial
Around the dose
- Clock: Classic medical mimic is bedtime. 2025–26 physique camp often pins AM fasted for lipolysis lore and to leave the night pulse alone. Split AM+PM shows up at higher IU. forum
- Empty stomach: Not the same insulin-blunts-secretagogue rule, but AM fasted + delay carbs is the fat-loss ritual. Bedtime users still avoid a huge late meal for sleep/glucose. forum
- Training: Not a gym-bag pump peptide. Lift in the day; pin on the chosen clock. forum
- Water / carpal: Tight rings or night hand numbness are treated as dose feedback, not a badge. forum
- After: Protein and lifting still do composition work. Glucose noise is the next-day watch. forum
Cycles people discuss
- Physique block length (common charts): ~8–16 weeks often cited; 12–16 weeks as a modal average in secondary bodybuilding guides; many recomp users extend to ~3–6 months. forum
- Long wellness runs: 3–6+ months continuous at low IU is common in anti-aging discourse; multi-year unsupervised high-dose use is where acromegaloid anecdotes concentrate. forum
- Minimum “give it time” narrative: Fat-loss/skin claims often framed as needing months, not a 2-week pump compound. forum
- 5-on/2-off or training-day-only variants: Used for cost, travel, or side management — not standardized medicine. forum
- Time off: Stop when goals/sides hit; some “bridge” with secretagogues (CJC/Ipa, sermorelin, MK-677) between GH kits — evidence for bridge superiority is lore. forum
- PCT (HGH alone): Generally not treated like AAS PCT; no standard SERM requirement for somatropin-only in community consensus. forum
- PCT (stacked): If stacked with suppressive AAS/SARMs, PCT follows those compounds — not the GH. forum
- 2026 lab cadence in physique threads: baseline IGF-1 + fasting glucose, then every ~6 weeks while titrating IU. A 1 IU start that doesn’t lift IGF-1 is a known “suppression without replacement” story before jumping. forum
- Clinical GHD: Continuous replacement under endocrine supervision with labs — not a “blast and cruise” aesthetic cycle. trial
- Exit / hold rules: Persistent CTS, uncontrolled edema, rising glucose/HbA1c, blood-pressure issues, or suspected tumor history → community and clinical guidance converge on stop/reduce and medical evaluation. trial
- Intermittent clinical note: Some approved contexts note limited data on intermittent vs continuous strategies — forum on/off patterns are not FDA templates. trial
Timing
- Downstream IGF-1: Circulating GH peak is brief; IGF-1 remains elevated longer (hours to a sustained higher set-point with chronic dosing) — many monitor morning IGF-1 as a crude exposure surrogate. forum
- Fragment contrast: HGH Frag 176-191 is a different molecule (fat-loss fragment lore) — not interchangeable with full 191aa somatropin and does not raise IGF-1 the same way. forum
- AM vs PM 2026: Bro fat-loss camp prefers AM fasted so the night endogenous pulse stays and overnight insulin resistance lore is lower; clinical/wellness camp still likes bedtime to mimic the nocturnal pulse. IGF-1 often doesn’t pick the winner. forum
- IV half-life: Very short (~0.4 h terminal in classic Genotropin-class PK) — not the practical community route. trial
- GENOTROPIN SC PK: In adult GHD after 0.03 mg/kg SC, mean Tmax was 5.9 hours and mean terminal half-life was 3.0 hours (95% CI 2.2–3.7). Other products, doses and populations can differ. trial
- Why daily dosing: Short plasma GH vs multi-day secretagogue or long-acting GH analogs; daily (or near-daily) SC is the default “HGH” protocol in forums. trial
- Bedtime rationale: Mimic natural nocturnal pulse; still standard in GHD and many wellness scripts. trial
- Long-acting contrast: Weekly/long-acting GH analogs (e.g., somapacitan-class discussion) exist medically; community “HGH” almost always means daily somatropin, not the weekly prodrugs. trial
More on what it is
- Why people search: Decades of bodybuilding, anti-aging-clinic, and GHD volume; top GH-axis keyword for fat loss, lean-mass look, recovery, and “anti-aging.” forum
- Risk frame: Gray-market underdosing, counterfeits, and mislabeled vials are widely discussed; chronic excess maps to acromegaloid change and glucose/insulin-resistance risk. forum
- Regulatory / sport: Prescription-controlled in many jurisdictions; WADA-prohibited for athletes; diversion and underground “kit” culture remain high-visibility. forum
- What it is: Recombinant somatropin — a 191-amino-acid protein identical in sequence to endogenous pituitary GH (modern rhGH / “191aa”). Distinct from older met-HGH/somatrem (192aa with N-terminal methionine). trial
- Mechanism (plain): GH-receptor signaling → lipolysis, protein synthesis support, nitrogen retention talk, and hepatic IGF-1 production; many “results” timelines track IGF-1 and fluid as much as true contractile tissue. trial
- Evidence posture: Strong clinical base for GHD and certain approved indications; athletic/anti-aging use is largely off-label. Short athletic reviews often show lean-mass gains with little clear strength or exercise-capacity win. trial
- Not a: Not an anabolic steroid, not a GH secretagogue (does not make the pituitary “pulse” GH — it is the hormone), not oral “HGH spray/pill” consumer products that claim true somatropin delivery. trial
- 191aa vs 192aa lore: Forums treat true 191aa somatropin as the gold standard; 192aa/met-HGH historical products were linked to higher antibody rates; gray-market “192aa” talk is mostly a quality/authenticity red flag. trial
- 2026 access is not the peptide Cat-2 fight: Somatropin is a licensed biologic (PHS Act 351). FDA Import Alert 66-71 (page updated 7 Apr 2026) treats imported lyophilized HGH as a finished biologic, not an API for 503A/503B compounding. trial
- Distribution law: 21 U.S.C. § 333(e) makes knowingly distributing HGH for non-authorized human uses (FDA names bodybuilding / anti-aging / athletic enhancement) a federal offense. This card maps talk only. trial
Stacks
- Testosterone / AAS + HGH: The classic mass or recomp stack; GH often credited for fat loss and “quality” while AAS drive most strength/size — high confound and additive side burden. forum
- HGH + insulin (“slin”): Nutrient-partitioning / fullness / paper-skin lore at high bodybuilding levels; hypoglycemia risk is severe; “HGH gut” narratives often involve insulin + high calories more than GH alone. forum
- HGH + IGF-1 LR3 or DES: Downstream hypertrophy layering talk; additional glucose and complexity risk. forum
- HGH + secretagogue bridge or alternate: CJC-1295 (DAC or no-DAC) + ipamorelin, sermorelin, GHRP-2/6, hexarelin, or MK-677 used to “support GH axis” between kits or instead of high-IU somatropin — different mechanism (pulse own GH vs inject GH). forum
- HGH-only low-IU wellness: Some prefer not stacking to isolate sides and cost. forum
- Cut stacks: HGH with T3, cardarine (GW), clenbuterol lore, or modern GLP-1s — multi-drug confounds; glucose and heart rate monitoring talk rises. forum
- Anavar / Primo + HGH (milder oral/inject AAS talk): Secondary guides present “quality recomp” stacks with lower androgen load than heavy bulks. forum
- Metformin or glucose-management co-talk: Sometimes discussed when GH worsens insulin sensitivity — not a free pass to keep high IU. forum
- Thyroid monitoring lore: Occasional hypothyroidism / T3-shift discussion in secondary sources; not universally observed in all clinic commentary. forum
- Secretagogue bridge still lore: CJC/IPA or sermorelin between kits — 2026 access made the bridge harder where those peptides aren’t filled. forum
Access talk
- Three shelves: brand pens (Genotropin / Norditropin / Omnitrope-class), diverted/pharma-looking kits, and research-chem “191aa” vials. IU labels on gray kits are the authenticity fight. forum
- Norditropin-class SKU churn (2025–26 practice talk): high-volume pen presentations getting discontinued shifts refill math — not a new IU protocol. forum
- Licensed biologic, not a 503A peptide: FDA Import Alert 66-71 (updated 7 Apr 2026) says imported HGH powder/injection is a finished biologic under PHS Act 351 and is not eligible for 503A/503B compounding exemptions. trial
- 21 U.S.C. § 333(e): Knowingly distributing, or possessing with intent to distribute, HGH for unauthorized human uses — FDA examples include bodybuilding, anti-aging, athletic enhancement — is a federal offense (up to 5 years; 10 if a minor). This card is discussion only. trial
- Not in April/July 2026 peptide PCAC headlines. Those votes do not legalize gray somatropin kits. trial
Labs people mention
- IGF-1 (age-adjusted, same lab) is the exposure surrogate people titrate. Morning draw; some hold the AM pin so fasting glucose isn’t an acute GH artifact. forum
- 2026 titration logs: 1 IU may not lift IGF-1 (endogenous suppression without replacement lore); 1.5–2 IU is where some first see a rise — individual, not a rule. anecdote
- Forum “200–300 ng/mL sweet spot / don’t chase 400+” is repeated on 2026 peptide sheets. Age-matched ranges differ; 350 can be normal at 20 and high at 45. forum
- If IGF-1 never moves at 2–4 IU: fake/underdosed kit is the first community suspicion before “non-responder.” forum
- Glucose panel: fasting glucose, A1c, sometimes fasting insulin/HOMA-IR. GH is diabetogenic in susceptible people — this is class evidence, not optional flavor text. trial
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
- Pens vs kits: Brand pens have their own diluent/device math. Underground lyophilized kits plus bacteriostatic water are a different error surface (IU vs mg, 191aa vs 192aa lore). Still no mix SOP here. forum
Watch for
- Cancer / IGF-1 theoretical risk: GH/IGF-1 growth pathways raise theoretical tumor-promotion concern; definitive proof that therapeutic or gym-dose GH causes cancer in healthy adults is not settled, but active malignancy is a clinical contraindication frame and forums debate long-term risk. forum
- “HGH gut” debate: Distended midsection in IFBB-era competitors is often blamed on GH; stronger community counter-argument points to insulin, food volume, visceral fat, and muscle hypertrophy of the abdominal wall — GH alone tends to reduce visceral fat via lipolysis. forum
- Counterfeit / underdosed kits: Financial waste and unknown contaminants; “no sides at 5 IU” can mean fake product rather than super-tolerability. forum
- Legal / doping: Controlled substance / prescription status varies by country; WADA banned; criminal diversion risk for non-prescribed supply. forum
- Not risk-free at “low” IU: Even wellness bands report edema/CTS in sensitive users; “1–2 IU is harmless” is not a clinical guarantee. forum
- Water / carpal / glucose remain the limiter in 2026 logs: edema and CTS at “it’s working / too much”; fasting glucose, A1c, and occasional metformin-talk when IU climbs. forumtrial
- US law (not “just another supplement”): HGH is not a typical DEA Schedule III listing, but distributing or possessing it with intent to distribute for non-authorized uses (including bodybuilding or anti-aging) is a separate federal offense. This card maps discussion only — it is not a way to obtain or use HGH, and it promises nothing. trial
- Peripheral edema: Hands, feet, face swelling — among the most common dose-related effects in trials and logs; often early. trial
- Carpal tunnel / paresthesias: Numbness, tingling, night hand symptoms from soft-tissue/fluid compression of the median nerve; dose reduction or stop often discussed. trial
- Arthralgia / myalgia / stiffness: Joint and muscle aches frequent at initiation or high IU; may improve after weeks or only after dose cut. trial
- Glucose / insulin resistance / diabetes risk: GH is diabetogenic in susceptible people — fasting glucose, OGTT, and HbA1c monitoring are standard caution language. trial
- Gynecomastia: Male breast-tissue enlargement listed in clinical GH contexts and secondary reviews; mechanism talk includes hormonal cross-talk; often confounded by concurrent AAS. trial
- Intracranial hypertension / headache with visual symptoms: Benign intracranial hypertension is a known GH-therapy risk signal (more emphasized in pediatric literature; still a stop-and-evaluate red flag). trial
- Acromegaly / irreversible tissue change: Chronic GH/IGF-1 excess → enlarged hands/feet/jaw, organomegaly, soft-tissue remodeling — the core long-term high-dose warning. trial
- Cardiovascular concern: Secondary sources discuss left-ventricular hypertrophy risk with excess GH; GHD replacement can be cardioprotective in deficiency — dose and context matter. trial
- Antibody / efficacy loss (historical 192aa): Met-HGH associated with higher anti-GH antibodies in older literature; modern 191aa is preferred. trial
- Hypoglycemia paradox note: Transient insulin-like action can occasionally lower glucose, but the dominant chronic concern is insulin resistance — do not confuse with insulin stacking hypos. trial
- Not a 503A peptide: “Compounded HGH” marketing is the identity red flag in 2026 access threads — biologics are outside that peptide-compounding story. trial
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.